Personal Genome Diagnostics' Circulating Tumor DNA technology highlighted in landmark study
2/21/2014
Personal Genome Diagnostics Inc. (PGDx), a provider of advanced cancer genome analysis and testing services, reported that its proprietary technology was used in a major new study being published in the journal Science Translational Medicine.
Advanced prostate cancer risk could be identified by genetic screening
2/21/2014
New research from the Institute of Cancer Research in the UK suggests that screening men with a family history of prostate cancer for certain gene mutations could identify those who are at increased risk of aggressive forms of the disease and need lifelong monitoring.
Added benefit of Afatinib depends on mutation status in non-small cell lung cancer
2/21/2014
Lung cancer patients with Del19 mutation benefit mostAfatinib (trade name: GIOTRIF) has been approved in Germany since September 2013 for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating EGF receptor mutations who have not been treated with an EGF receptor tyrosine-kinase inhibitor (EGFR TKI).
Reduced risk of cervical lesions associated with HPV vaccination in Denmark
2/21/2014
A reduced risk of cervical lesions among Danish girls and women at the population level is associated with use of a quadrivalent HPV vaccine after only six years, according to a new study published in the Journal of the National Cancer Institute.Two HPV vaccines are currently available and have proven to be highly effective against HPV16/18-associated cervical cancer.
Overall survival not improved by adding bevacizumab to initital glioblastoma treatment
2/21/2014
Glioblastoma (GBM) is the most common primary malignant adult brain tumor and, despite treatment advances in recent years, the average survival of patients enrolled in clinical trials is less than 16 months with few patients living beyond five years.
Scientists challenge the genetic interpretation of biology
2/21/2014
A proposal for reformulating the foundations of biology, based on the 2nd law of thermodynamics and which is in sharp contrast to the prevailing genetic view, is published in the Journal of the Royal Society Interface under the title "Genes without prominence: a reappraisal of the foundations of biology".
Computer models created to explore the complex biochemical processes that drive cancer growth
2/21/2014
Life can be messy at all scales, requiring different organizational strategies -- from cleaning the house, to removing damaged or expired cells from the body to avoid cancer progression.In a messy house, people use computers to manage paper and photo clutter; companies use computer systems to track their inventory. Now a team of researchers at Vanderbilt University in Nashville, Tenn.
Advanced prostate cancer risk could be identified by genetic screening
2/21/2014
New research from the Institute of Cancer Research in the UK suggests that screening men with a family history of prostate cancer for certain gene mutations could identify those who are at increased risk of aggressive forms of the disease and need lifelong monitoring.
Added benefit of Afatinib depends on mutation status in non-small cell lung cancer
2/21/2014
Lung cancer patients with Del19 mutation benefit mostAfatinib (trade name: GIOTRIF) has been approved in Germany since September 2013 for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating EGF receptor mutations who have not been treated with an EGF receptor tyrosine-kinase inhibitor (EGFR TKI).
Reduced risk of cervical lesions associated with HPV vaccination in Denmark
2/21/2014
A reduced risk of cervical lesions among Danish girls and women at the population level is associated with use of a quadrivalent HPV vaccine after only six years, according to a new study published in the Journal of the National Cancer Institute.Two HPV vaccines are currently available and have proven to be highly effective against HPV16/18-associated cervical cancer.